"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
Descriptor ID |
D014157
|
MeSH Number(s) |
D12.776.930
|
Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 5 | 2 | 7 |
1996 | 13 | 2 | 15 |
1997 | 6 | 4 | 10 |
1998 | 8 | 3 | 11 |
1999 | 6 | 1 | 7 |
2000 | 7 | 2 | 9 |
2001 | 8 | 4 | 12 |
2002 | 17 | 8 | 25 |
2003 | 15 | 6 | 21 |
2004 | 8 | 8 | 16 |
2005 | 7 | 5 | 12 |
2006 | 10 | 3 | 13 |
2007 | 6 | 1 | 7 |
2008 | 8 | 3 | 11 |
2009 | 4 | 8 | 12 |
2010 | 7 | 5 | 12 |
2011 | 12 | 7 | 19 |
2012 | 11 | 3 | 14 |
2013 | 7 | 12 | 19 |
2014 | 8 | 15 | 23 |
2015 | 7 | 8 | 15 |
2016 | 4 | 3 | 7 |
2017 | 7 | 4 | 11 |
2018 | 5 | 3 | 8 |
2019 | 3 | 9 | 12 |
2020 | 3 | 3 | 6 |
2021 | 10 | 6 | 16 |
2022 | 2 | 9 | 11 |
2023 | 1 | 4 | 5 |
2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024 Nov 04; 13(21).
-
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. J Med Chem. 2024 Sep 26; 67(18):16270-16295.
-
Differentially methylated regions interrogated for metastable epialleles associate with offspring adiposity. Epigenomics. 2024; 16(18):1215-1230.
-
Endothelial Chromatin-Remodeling Enzymes Regulate the Production of Critical ECM Components During Murine Lung Development. Arterioscler Thromb Vasc Biol. 2024 Aug; 44(8):1784-1798.
-
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C. J Natl Cancer Inst. 2023 11 08; 115(11):1355-1363.
-
PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves. Circ Res. 2023 09; 133(6):463-480.
-
Analysis of gene duplication within the Arabidopsis NUCLEAR FACTOR Y, subunit B (NF-YB) protein family reveals domains under both purifying and diversifying selection. PLoS One. 2023; 18(8):e0289332.
-
Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT). Histopathology. 2023 Oct; 83(4):546-558.
-
Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge. Arterioscler Thromb Vasc Biol. 2023 08; 43(8):1412-1428.
-
Structural and Functional Characterization of Rv0792c from Mycobacterium tuberculosis: Identifying Small Molecule Inhibitor against HutC Protein. Microbiol Spectr. 2023 Feb 14; 11(1):e0197322.